Diaryl urea derivatives in the treatment of protein kinase dependent diseases

Details for Australian Patent Application No. 2009203096 (hide)

Owner Novartis AG

Inventors Roesel, Johannes; Imbach, Patricia; Caravatti, Giorgio; Guagnano, Vito; Vaupel, Andrea; Garcia-Echeverria, Carlos; Masuya, Keiichi; Floersheimer, Andreas; Bold, Guido

Agent Davies Collison Cave

Pub. Number AU-A-2009203096

Parent 2004292773

Filing date 30 July 2009

Wipo publication date 20 August 2009

International Classifications

C07D 239/34 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/46 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

13 August 2009 Complete Application Filed

20 August 2009 Application Open to Public Inspection

  Published as AU-A-2009203096

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009203097-Medical implants and methods

2009203095-Systems and methods for enhancing electronic communication security